antitussive and antiallergic therapeutics (ENovate Biolife)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameantitussive and antiallergic therapeutics (ENovate Biolife)
Drug Alias NameE-AR-07E-AR-03
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsHistamine release modulatorsInterleukin-5 receptors inhibitors +[6] 
TargetsNuclear factor NF-kappa-B complexInterleukin-5 receptorsImmunoglobulin +[4] 
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnovate Biolife
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnovate Biolife
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A